—
C+
C+ The full Closelook — membership. Open the C+ overview

Pro Medicus Ltd (PME.AX) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Pro Medicus Ltd

PME.AX in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Pro Medicus develops and sells medical imaging software, chiefly its Visage platform, used by radiologists and hospitals to view, store and share diagnostic scans such as CT and MRI images. The company is based in Melbourne, Australia and licenses its software to hospital groups and diagnostic imaging providers in several countries. Its contracts are typically long-term and tied to the volume of images processed.
Where it sits in the stack
Pro Medicus carries no seat in Closelook's indices, so it sits outside our AI build-out sleeves; within our wider universe it belongs to the healthcare software sector, applying cloud and image-processing tools rather than supplying AI infrastructure itself.
Who it is priced against
Closelook's peer group has not classified this stock yet; the market names Sectra as the closest listed competitor in cloud-based medical imaging software.
Why Closelook tracks it
Pro Medicus holds no seat in Closelook's indices, and no Closelook score exists yet; the diary has not quoted it in earlier editions.
What the diary watches
The diary watches whether the stock's slide well below its 50-day and 200-day averages, and well off its high, marks a lasting derating or a pause before recovery.

Pro Medicus Ltd (PME.AX) trades on the AU exchange in Australia.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for PME.AX, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Health Information Services · 8 names with week and year-to-date

Peer group

Health Information Services

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against PME.AX on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Dividends and capital return trailing yield 0.41%, semi-annual · last 0.37 AUD on 2026-09-07

Dividends and capital return

What PME.AX pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 0.69 AUD per share · a 0.41% yield on the 2026-09-18 close 2 distributions, paid twice a year 2026-09-18
  • Change on the year +25.5% against the prior twelve months prior twelve months 0.55 AUD per share
  • Last distribution 0.37 AUD per share as the price series records it, within days of the ex-date 2026-09-07
  • By calendar year 2024: 0.40 AUD (partial) · 2025: 0.55 AUD · 2026: 0.69 AUD to date first distribution recorded in the three-year window: 2024-02-29

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 50/100 · S&P 500 fund at 49, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-18
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 97th percentile of the window, +4.9% over 20 sessions. Factor regime → 2026-09-18
  • Sovereign pressure Index 0.07 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-18

FAQ · from the current data · as of 2026-09-19

Quick answers

What is Pro Medicus Ltd (PME.AX)?

Pro Medicus Ltd trades as PME.AX on the AU exchange (Australia) in the Closelook research universe, as of the registry build of 2026-09-19.

Is PME.AX in a Closelook index?

Not currently — Pro Medicus Ltd is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-19.

Where does PME.AX trade against its moving averages?

Pullback inside an uptrend stack: Trades -4.3% vs the 50-day and +2.2% vs the 200-day average, 46.8% below the 52-week high and +57.8% off the 52-week low; a golden cross printed 30 sessions ago. Computed from daily closes. As of 2026-09-18 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Pro Medicus Ltd do?

Pro Medicus develops and sells medical imaging software, chiefly its Visage platform, used by radiologists and hospitals to view, store and share diagnostic scans such as CT and MRI images. The company is based in Melbourne, Australia and licenses its software to hospital groups and diagnostic imaging providers in several countries. Its contracts are typically long-term and tied to the volume of images processed. Closelook's peer group has not classified this stock yet; the market names Sectra as the closest listed competitor in cloud-based medical imaging software.

Where does Pro Medicus Ltd sit in the AI build-out?

Pro Medicus carries no seat in Closelook's indices, so it sits outside our AI build-out sleeves; within our wider universe it belongs to the healthcare software sector, applying cloud and image-processing tools rather than supplying AI infrastructure itself. Pro Medicus holds no seat in Closelook's indices, and no Closelook score exists yet; the diary has not quoted it in earlier editions.

Does Pro Medicus Ltd pay a dividend?

Pro Medicus Ltd has paid 0.69 AUD per share over the last twelve months, paid twice a year, a trailing yield of 0.41% on the 2026-09-18 close; the last distribution recorded in the price series was 0.37 AUD on 2026-09-07. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for PME.AX, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Health Information Services, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.